Showing results (401-410 of 699) with videos related to

Sort By:
Pageof 70
European Heart Journal. Cardiovascular Pharmacotherapy|October 9, 2024
Hypokalaemia in patients with type 2 diabetes and chronic kidney disease: the effect of finerenone-a FIDELITY analysisBertram Pitt, Rajiv Agarwal, Stefan D Anker, et al.
Kidney International|April 23, 2025
Analysis of the prespecified FIDELITY pooled patient dataset examined the efficacy and safety of finerenone in patients with an acute change in estimated glomerular filtration rateSankar D Navaneethan, Stefan D Anker, Gerasimos Filippatos, et al.
Cardiovascular Diabetology|May 21, 2015
Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetesBernt Johan von Scholten, Henrik Reinhard, Tine Willum Hansen, et al.
Journal of Diabetes and Its Complications|December 8, 2024
Kidney fat by magnetic resonance spectroscopy in type 2 diabetes with chronic kidney diseaseNiels Sondergaard Heinrich, Rune Ploegstra Pedersen, Mark Bitsch Vestergaard, et al.
Diabetes, Obesity & Metabolism|July 29, 2025
The Steno 1 study: Multifactorial intervention to reduce cardiovascular disease in type 1 diabetes-rationale and protocol of the prospective, randomized, open-labelled multicentre studyElisabeth B Stougaard, Mads R Andersen, Jonatan I Bagger, et al.
BMJ Open Diabetes Research & Care|September 14, 2021
Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trialEmilie H Zobel, Asger Wretlind, Rasmus S Ripa, et al.
Cardiovascular Diabetology|November 26, 2022
The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitusCarlos Puig-Jové, Josep Julve, Esmeralda Castelblanco, et al.
Diabetes Care|January 13, 2017
Systems Biology-Derived Biomarkers to Predict Progression of Renal Function Decline in Type 2 DiabetesGert Mayer, Hiddo J L Heerspink, Constantin Aschauer, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 14, 2026
Finerenone in People with Chronic Kidney Disease, Type 2 Diabetes, and History of NephrectomyJair Munoz Mendoza, Matthew R Weir, Stefan D Anker, et al.
Clinical Kidney Journal|February 23, 2024
Dapagliflozin in chronic kidney disease: cost-effectiveness beyond the DAPA-CKD trialPhil McEwan, Jason A Davis, Peter D Gabb, et al.
Pageof 70